Have a personal or library account? Click to login
The influence of folate pathway polymorphisms on high-dose methotrexaterelated toxicity and survival in children with non-Hodgkin malignant lymphoma Cover

The influence of folate pathway polymorphisms on high-dose methotrexaterelated toxicity and survival in children with non-Hodgkin malignant lymphoma

Radiology and Oncology
Volume 48 (2014): Issue 3 (September 2014)
By: Nina Erculj,  Barbara Faganel Kotnik,  Marusa Debeljak,  Janez Jazbec and  Vita Dolzan  
Open Access
|Jul 2014

Authors

Nina Erculj

Barbara Faganel Kotnik

Marusa Debeljak

Janez Jazbec

Vita Dolzan

vita.dolzan@mf.uni-lj.si

DOI: https://doi.org/10.2478/raon-2013-0076 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 289 - 292
Submitted on: Sep 1, 2013
Accepted on: Sep 16, 2013
Published on: Jul 10, 2014
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
childhood,
non-Hodgkin lymphoma,
folate pathway,
polymorphism,
high-dose methotrexate,
toxicity
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2014 Nina Erculj, Barbara Faganel Kotnik, Marusa Debeljak, Janez Jazbec, Vita Dolzan, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 48 (2014): Issue 3 (September 2014)Next article